Your session is about to expire
← Back to Search
Contrast Enhanced Digital Mammography for Breast Cancer
Study Summary
This trial is testing how well contrast enhanced mammography can diagnose patients with suspicious breast findings. The hope is that it will help to reclassify findings that would otherwise require a biopsy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the intent of this experimental protocol?
"The main outcome of this medical experiment, which is to be evaluated over the course of one year, will measure the False negative rate of MM. Additionally, secondary objectives include assessing Positive predictive value with CEM and US as well as Negative predictive values for both CEM and MM."
Is participation in this research endeavor still open to qualified subjects?
"According to clinicaltrials.gov, this research initiative is not currently recruiting for participants. This study was initially listed on June 23rd 2020 with its last edit occurring on August 15th 2022; however, there are still 2289 other trials actively taking enrolments at present."
Is it permissible for me to join this clinical examination?
"Participants that seek admittance to this clinical trial must have breast cancer and fall between 30 and 80 years of age. Currently, recruitment is underway for a total of 107 qualifying subjects."
Is the eligibility age range for this trial inclusive of persons fifty years or older?
"The prerequisites for entry into this clinical trial stipulate that candidates must be aged between 30 and 80. Those under 18 years of age have 64 studies available, while those over 65 can choose from 2207 trials instead."
Share this study with friends
Copy Link
Messenger